Reagents and consumables

Ended Awarded Last action

Contract number
75N91019F00139
Awardee
Awarding agency
Obligated
$74,002

Award facts

Opportunity
Contract value 100% obligated
$74,001.50 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
325413 In-Vitro Diagnostic Substance Manufacturing
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Not Competed Only One Source
Pricing
Firm Fixed Price
Place of performance
Castleton, IN 46256, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action P00001 · To DE-obligate funds from FY2019 expiring lines in accordance with NIH oalm communication 23-18 -$403
Original award $74,405

Quick answers

Who was awarded contract 75N91019F00139?

75N91019F00139 was awarded to Roche Diagnostics Corporation by National Cancer Institute (National Institutes of Health) on August 8, 2019.

How much is contract 75N91019F00139 worth?

The government has obligated $74,002 on 75N91019F00139.

Is contract 75N91019F00139 an order under another contract?

Yes. 75N91019F00139 is a delivery order under HHSN261201700010I, an indefinite delivery contract.

Was contract 75N91019F00139 competed?

The extent of competition for 75N91019F00139 was not competed.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award